TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards November 5, 1982
TCL Archive Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19 October 5, 1990
